10May/13

Protein Reverses Age-related Heart Failure – Bioscience Technology – Bioscience Technology


Bioscience Technology

Protein Reverses Age-related Heart Failure – Bioscience Technology
Bioscience Technology
Even more important than the implications for the treatment of diastolic heart failure, the finding by Richard T. Lee, a Harvard Medical School professor at the hospital, and Amy Wagers, a professor in Harvard’s Department of Stem Cell and Regenerative
Mouse blood swap reverses age-related heart failure – USA TodayUSA TODAY
Blood ‘Youth’ Hormone Reverses Aging in Mouse HeartsMedical Daily
Factor That Reverses Aging of Heart DiscoveredHarvard Magazine
Daily Mail –NHS Choices
all 28 news articles »
10May/13

Novel Hormone Capable of Reversing Age-Related Heart Failure Found – TopNews Arab Emirates


TopNews Arab Emirates

Novel Hormone Capable of Reversing Age-Related Heart Failure Found
TopNews Arab Emirates
They can carry out further study in order to know about the form of heart failure that occurs among elderly. “We have been working on this concept for several years that there was something in the young blood that could turn the clock back”, said Lee.
Growth Hormone That Can Reverse Age-Related Heart Failure? Scientists Swap Latinos Post
New Anti-Ageing Treatment For The Heart – iTech PostiTech Post

all 3 news articles »

10May/13

Rejuvenating hormone can reverse heart failure symptoms – Zee News – Zee News


Zee News

Rejuvenating hormone can reverse heart failure symptoms – Zee News
Zee News
Stem Cell Institute and Brigham and Women`s Hospital said. Heart failure is a condition in which the heart can`t pump enough blood to meet the body`s needs, causing shortness of breath and fatigue, and it is becoming increasingly prevalent in the
Mouse blood swap reverses age-related heart failure – USA TodayUSA TODAY
Blood ‘Youth’ Hormone Reverses Aging in Mouse HeartsMedical Daily
Factor That Reverses Aging of Heart DiscoveredHarvard Magazine
Daily Mail –Boston Globe –Science Codex
all 20 news articles »
10May/13

Trevena and Forest Labs collaborate on TRV027 for acute heart failure – The Pharma Letter

Trevena and Forest Labs collaborate on TRV027 for acute heart failure
The Pharma Letter
Trevena expects to commence a 500-patient multicenter Phase IIb clinical trial in acute decompensated heart failure (ADHF) by year end. Specific terms of the transaction were not disclosed but the agreement includes a $30 million equity investment by
Forest Labs Bets Up To $460M on Trevena Heart Failure DrugGenetic Engineering News
Trevena Raises $60M Series C, Strikes $430M Option Deal With Forest LabsDow Jones Bankruptcy & Debt (registration)
Trevena lands $430M Forest deal, $60M venture round as heart drug heads to FierceBiotech

all 6 news articles »